Fondaparinux as a novel therapeutic alternative in a patient with heparin allergy.
Maetzke
J
J
Department of Dermatology and Allergy University of Ulm Maienweg 12 89081 Ulm, Germany.
Hinrichs
R
R
Staib
G
G
Scharffetter-Kochanek
K
K
D000925:Anticoagulants / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000209:etiology*; D005260:Female; D000077425:Fondaparinux; D006493:Heparin / Q000009:adverse effects; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D008970:Molecular Weight; D011134:Polysaccharides / Q000627:therapeutic use*; D020246:Venous Thrombosis / Q000517:prevention & control*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D011134:Polysaccharides; D006493:Heparin; D000077425:Fondaparinux